NovelStem International Corp. Share Price
Equities
NSTM
US67001V1098
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 USD | 0.00% | 0.00% | -4.61% |
Sales 2022 | 0.01 1 | Sales 2023 | 0.01 1 | Capitalization | 2.95M 246M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -4M -334M | EV / Sales 2022 | 75,72,03,750 x |
Net Debt 2022 | 282K 23.53M | Net Debt 2023 | 3.52M 294M | EV / Sales 2023 | 53,91,98,333 x |
P/E ratio 2022 |
-9.39
x | P/E ratio 2023 |
-0.7
x | Employees | 15 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 33.68% |
Current month | -14.29% | ||
1 month | -14.29% | ||
3 months | -24.05% | ||
6 months | -54.23% | ||
Current year | -4.61% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 70 | 22/93/22 | |
Director of Finance/CFO | 61 | 29/22/29 | |
Jan Loeb
CHM | Chairman | 65 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Seltzer
BRD | Director/Board Member | 64 | - |
Founder | 70 | 22/93/22 | |
Jan Loeb
CHM | Chairman | 65 | 01/18/01 |
1st Jan change | Capi. | |
---|---|---|
-4.61% | 2.81M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NSTM Stock